Immedica Pharma AB, a leading global rare disease company, and Marinus Pharmaceuticals, Inc, a pharmaceutical company committed to improving the lives of patients with...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Exicure, Inc, has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. on December 24, 2024, aimed at the acquisition...
Frost & Sullivan researched the bioinformatics-based drug discovery and development industry, and based on its analysis results, recognized DNAnexus, provider of the leading enterprise platform...
